RC
RDY icon

RegentAtlantic Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

RegentAtlantic Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,500
Closed -$15.1K – 804
2014
Q4 		$15.1K Buy
+1,500
New +$15.8K ﹤0.01% 815

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RegentAtlantic Capital's RDY Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Dr. Reddy's Laboratories (RDY) in Q1 2015, closing a stake of 1,500 shares — an estimated $15.1K sold.

RegentAtlantic Capital first reported a position in RDY in Q4 2014 and held it in 1 quarter. The position peaked at $15.1K in Q4 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q1 2015.

  • RegentAtlantic Capital reported no remaining Dr. Reddy's Laboratories position as of Q1 2015 after selling out during the quarter.
  • RegentAtlantic Capital sold 1,500 Dr. Reddy's Laboratories shares in Q1 2015, an estimated $15.1K.
  • RegentAtlantic Capital first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 1 quarter.
  • RegentAtlantic Capital's Dr. Reddy's Laboratories position peaked at $15.1K in Q4 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.